{"transactions":[{"id":5857,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP, Access, Policy & Comms"}}],"security":"Common Stock","published_at":"2026-08-13T21:02:25.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":135,"value":1350000.0,"ownership":{"direct":true},"balance_after":36613.127,"source":{"system":"sec-edgar","filing":"0000310158-26-000223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000223/form4.xml","form_type":"4"}},{"id":6206,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP, Access, Policy & Comms"}}],"security":"Common Stock","published_at":"2026-08-07T20:17:06.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":131,"value":1965000.0,"ownership":{"direct":true},"balance_after":46613.127,"source":{"system":"sec-edgar","filing":"0000310158-26-000213","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000213/form4.xml","form_type":"4"}},{"id":748056,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:06.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526259534/ownership.xml","form_type":"4"}},{"id":10099,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP, Access, Policy & Comms"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T15:36:35.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":19402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029."}],"balance_after":19402,"derivative":{"exercise_price":113.15,"exercise_date":"2027-05-05","expiration_date":"2036-05-04","underlying":"Common Stock","underlying_shares":19402},"source":{"system":"sec-edgar","filing":"0000310158-26-000117","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000117/form4.xml","form_type":"4"}},{"id":10098,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP, Access, Policy & Comms"}}],"security":"Restricted Stock Unit","published_at":"2026-05-07T15:36:35.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":6628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029."}],"balance_after":6628,"derivative":{"exercise_date":"2027-05-05","expiration_date":"2029-05-05","underlying":"Common Stock","underlying_shares":6628},"source":{"system":"sec-edgar","filing":"0000310158-26-000117","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000117/form4.xml","form_type":"4"}},{"id":10375,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP, Access, Policy & Comms"}}],"security":"Restricted Stock Unit","published_at":"2026-05-01T22:54:19.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":false,"shares":1967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028."}],"balance_after":3935,"derivative":{"exercise_date":"2026-04-29","expiration_date":"2028-04-29","underlying":"Common Stock","underlying_shares":1967},"source":{"system":"sec-edgar","filing":"0000310158-26-000102","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000102/form4.xml","form_type":"4"}},{"id":10374,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP, Access, Policy & Comms"}}],"security":"Common Stock","published_at":"2026-05-01T22:54:19.000Z","date":"2026-04-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":969,"price":110.03,"value":106619.07,"ownership":{"direct":true},"balance_after":61613.127,"source":{"system":"sec-edgar","filing":"0000310158-26-000102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000102/form4.xml","form_type":"4"}},{"id":10373,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP, Access, Policy & Comms"}}],"security":"Common Stock","published_at":"2026-05-01T22:54:19.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":true,"shares":1967,"price":110.03,"value":216429.01,"ownership":{"direct":true},"balance_after":62582.127,"source":{"system":"sec-edgar","filing":"0000310158-26-000102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000102/form4.xml","form_type":"4"}},{"id":14169,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:02:53.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":121.4562,"value":1214562.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.4400 to $121.5150, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote."}],"balance_after":60615.127,"source":{"system":"sec-edgar","filing":"0000310158-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000052/form4.xml","form_type":"4"}},{"id":14363,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-02-09T21:04:59.000Z","date":"2026-02-09","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":118.4101,"value":1184101.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.4000 to $118.4502, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote."}],"balance_after":70615.127,"source":{"system":"sec-edgar","filing":"0000310158-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000048/form4.xml","form_type":"4"}},{"id":14567,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-02-06T21:10:16.000Z","date":"2026-02-05","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":121.8838,"value":2437676.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.8400 to $121.9700, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote."}],"balance_after":80615.127,"source":{"system":"sec-edgar","filing":"0000310158-26-000034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000034/form4.xml","form_type":"4"}},{"id":15074,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-01-28T21:08:02.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":9865,"price":107.4,"value":1059501.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/23. Performance shares were paid out at 94 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":100615.127,"source":{"system":"sec-edgar","filing":"0000310158-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000014/form4.xml","form_type":"4"}},{"id":21365,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-08-05T12:43:24.000Z","date":"2025-08-04","kind":"exercise","planned":false,"acquired":false,"shares":36903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025 or, if such date was not a business day, the business day immediately thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025 or, if such date was not a business day, the business day immediately thereafter."}],"balance_after":0,"derivative":{"exercise_date":"2023-08-03","expiration_date":"2025-08-03","underlying":"Common Stock","underlying_shares":36903},"source":{"system":"sec-edgar","filing":"0000310158-25-000010","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000010/form4.xml","form_type":"4"}},{"id":21364,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2025-08-05T12:43:24.000Z","date":"2025-08-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":18175,"price":79.29,"value":1441095.75,"ownership":{"direct":true},"balance_after":89233.973,"source":{"system":"sec-edgar","filing":"0000310158-25-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000010/form4.xml","form_type":"4"}},{"id":21363,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2025-08-05T12:43:24.000Z","date":"2025-08-04","kind":"exercise","planned":false,"acquired":true,"shares":36903,"price":79.29,"value":2926038.87,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":107408.973,"source":{"system":"sec-edgar","filing":"0000310158-25-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000010/form4.xml","form_type":"4"}},{"id":1119717,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:19.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2025-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083052/ownership.xml","form_type":"4"}},{"id":24662,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-01T21:45:16.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":26867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028."}],"balance_after":26867,"derivative":{"exercise_price":84.71,"exercise_date":"2026-04-29","expiration_date":"2035-04-28","underlying":"Common Stock","underlying_shares":26867},"source":{"system":"sec-edgar","filing":"0001127602-25-013018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760225013018/form4.xml","form_type":"4"}},{"id":24661,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-05-01T21:45:16.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":5902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028."}],"balance_after":5902,"derivative":{"exercise_date":"2026-04-29","expiration_date":"2028-04-29","underlying":"Common Stock","underlying_shares":5902},"source":{"system":"sec-edgar","filing":"0001127602-25-013018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760225013018/form4.xml","form_type":"4"}},{"id":29625,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2025-01-29T23:07:13.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":28158,"price":97.94,"value":2757794.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 8/3/22. Performance shares were paid out at 169 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":69143.918,"source":{"system":"sec-edgar","filing":"0001127602-25-002334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760225002334/form4.xml","form_type":"4"}},{"id":1343035,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T12:22:54.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":39086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to one-third of the shares subject to the option on the first anniversary of the date of grant and in equal monthly installments as to the remainder of the shares for two years thereafter, subject to the Reporting Person's continued service with the Company through each vesting date."}],"balance_after":39086,"derivative":{"exercise_price":28.3,"expiration_date":"2034-12-02","underlying":"Common Stock","underlying_shares":39086},"source":{"system":"sec-edgar","filing":"0000950170-24-133080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024133080/ownership.xml","form_type":"4"}},{"id":37360,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-08-06T16:20:35.000Z","date":"2024-08-05","kind":"exercise","planned":false,"acquired":false,"shares":36901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025 or, if such date is not a business day, the business day immediately thereafter."}],"balance_after":36903,"derivative":{"exercise_date":"2023-08-03","expiration_date":"2025-08-03","underlying":"Common Stock","underlying_shares":36901},"source":{"system":"sec-edgar","filing":"0001127602-24-021690","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224021690/form4.xml","form_type":"4"}},{"id":37359,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2024-08-06T16:20:35.000Z","date":"2024-08-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":17412,"price":115.2,"value":2005862.4,"ownership":{"direct":true},"balance_after":40369.593,"source":{"system":"sec-edgar","filing":"0001127602-24-021690","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224021690/form4.xml","form_type":"4"}},{"id":37358,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2024-08-06T16:20:35.000Z","date":"2024-08-05","kind":"exercise","planned":false,"acquired":true,"shares":36901,"price":115.2,"value":4250995.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":57781.593,"source":{"system":"sec-edgar","filing":"0001127602-24-021690","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224021690/form4.xml","form_type":"4"}},{"id":41496,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T20:22:17.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":29297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal installments on 4/30/2025, 4/30/2026 and 4/30/2027."}],"balance_after":29297,"derivative":{"exercise_price":129.22,"exercise_date":"2025-04-30","expiration_date":"2034-04-29","underlying":"Common Stock","underlying_shares":29297},"source":{"system":"sec-edgar","filing":"0001127602-24-013976","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224013976/form4.xml","form_type":"4"}},{"id":53957,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-08-04T20:17:26.000Z","date":"2023-08-03","kind":"exercise","planned":false,"acquired":false,"shares":36901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025."}],"balance_after":73804,"derivative":{"exercise_date":"2023-08-03","expiration_date":"2025-08-03","underlying":"Common Stock","underlying_shares":36901},"source":{"system":"sec-edgar","filing":"0001127602-23-022015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223022015/form4.xml","form_type":"4"}},{"id":53956,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2023-08-04T20:17:26.000Z","date":"2023-08-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":17989,"price":105.7,"value":1901437.3,"ownership":{"direct":true},"balance_after":20352.684,"source":{"system":"sec-edgar","filing":"0001127602-23-022015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223022015/form4.xml","form_type":"4"}},{"id":53955,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2023-08-04T20:17:26.000Z","date":"2023-08-03","kind":"exercise","planned":false,"acquired":true,"shares":36901,"price":105.7,"value":3900435.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":38341.684,"source":{"system":"sec-edgar","filing":"0001127602-23-022015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223022015/form4.xml","form_type":"4"}},{"id":56301,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-04T21:43:51.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":34578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026."}],"balance_after":34578,"derivative":{"exercise_price":117.89,"exercise_date":"2024-05-02","expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":34578},"source":{"system":"sec-edgar","filing":"0001127602-23-014541","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223014541/form4.xml","form_type":"4"}},{"id":64628,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-08-04T20:04:11.000Z","date":"2022-08-03","kind":"grant","acquired":true,"shares":110705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025."}],"balance_after":110705,"derivative":{"exercise_date":"2023-08-03","expiration_date":"2025-08-03","underlying":"Common Stock","underlying_shares":110705},"source":{"system":"sec-edgar","filing":"0001127602-22-020472","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222020472/form4.xml","form_type":"4"}},{"id":2380141,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:15:56.000Z","date":"2022-02-18","kind":"other","acquired":false,"shares":2851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":9668,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2851},"source":{"system":"sec-edgar","filing":"0001127602-22-006266","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006266/form4.xml","form_type":"4"}},{"id":2380140,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:15:56.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":1981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":12519,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1981},"source":{"system":"sec-edgar","filing":"0001127602-22-006266","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006266/form4.xml","form_type":"4"}},{"id":2380139,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Common Stock","published_at":"2022-02-23T21:15:56.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":879,"price":209.79,"value":184405.41,"ownership":{"direct":true},"balance_after":7364,"source":{"system":"sec-edgar","filing":"0001127602-22-006266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006266/form4.xml","form_type":"4"}},{"id":2380138,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Common Stock","published_at":"2022-02-23T21:15:56.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":1981,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8243,"source":{"system":"sec-edgar","filing":"0001127602-22-006266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006266/form4.xml","form_type":"4"}},{"id":2395645,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:15:46.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":2480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":3818,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":2480},"source":{"system":"sec-edgar","filing":"0001127602-22-004989","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004989/form4.xml","form_type":"4"}},{"id":2395644,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:15:46.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":1336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":6298,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1336},"source":{"system":"sec-edgar","filing":"0001127602-22-004989","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004989/form4.xml","form_type":"4"}},{"id":2395643,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:15:46.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":2395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":2395},"source":{"system":"sec-edgar","filing":"0001127602-22-004989","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004989/form4.xml","form_type":"4"}},{"id":2395642,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:15:46.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":1261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":2395,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1261},"source":{"system":"sec-edgar","filing":"0001127602-22-004989","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004989/form4.xml","form_type":"4"}},{"id":2395641,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Common Stock","published_at":"2022-02-15T21:15:46.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":1189,"price":214.59,"value":255147.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 21, 2022."}],"balance_after":6262,"source":{"system":"sec-edgar","filing":"0001127602-22-004989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004989/form4.xml","form_type":"4"}},{"id":2395640,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Common Stock","published_at":"2022-02-15T21:15:46.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":593,"price":214.59,"value":127251.87,"ownership":{"direct":true},"balance_after":7451,"source":{"system":"sec-edgar","filing":"0001127602-22-004989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004989/form4.xml","form_type":"4"}},{"id":2395639,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Common Stock","published_at":"2022-02-15T21:15:46.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":1336,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8044,"source":{"system":"sec-edgar","filing":"0001127602-22-004989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004989/form4.xml","form_type":"4"}},{"id":2395638,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Common Stock","published_at":"2022-02-15T21:15:46.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":560,"price":214.59,"value":120170.4,"ownership":{"direct":true},"balance_after":6708,"source":{"system":"sec-edgar","filing":"0001127602-22-004989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004989/form4.xml","form_type":"4"}},{"id":2395637,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Common Stock","published_at":"2022-02-15T21:15:46.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":1261,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7268,"source":{"system":"sec-edgar","filing":"0001127602-22-004989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004989/form4.xml","form_type":"4"}},{"id":2399481,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Restricted Stock Unit","published_at":"2022-02-14T21:26:20.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":9090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":9090,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":9090},"source":{"system":"sec-edgar","filing":"0001127602-22-004801","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004801/form4.xml","form_type":"4"}},{"id":2429259,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Common Stock","published_at":"2022-01-21T21:47:37.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":3088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019.  The shares will vest on February 12, 2022."}],"balance_after":6007,"source":{"system":"sec-edgar","filing":"0001127602-22-001862","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222001862/form4.xml","form_type":"4"}},{"id":2676509,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"Head of Glob Prod Strat & Com"}}],"security":"Common Stock","published_at":"2021-06-09T23:04:54.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":3087,"price":440,"value":1358280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":2919,"source":{"system":"sec-edgar","filing":"0001127602-21-019552","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221019552/form4.xml","form_type":"4"}},{"id":2844482,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2021-02-22T21:11:27.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":14500,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001127602-21-006982","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006982/form4.xml","form_type":"4"}},{"id":2856333,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:58:28.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":2194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":7634,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":2194},"source":{"system":"sec-edgar","filing":"0001127602-21-006270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006270/form4.xml","form_type":"4"}},{"id":2856332,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:58:28.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":1622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":9828,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1622},"source":{"system":"sec-edgar","filing":"0001127602-21-006270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006270/form4.xml","form_type":"4"}},{"id":2856331,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:58:28.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":2118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":3656,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":2118},"source":{"system":"sec-edgar","filing":"0001127602-21-006270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006270/form4.xml","form_type":"4"}},{"id":2856330,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:58:28.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":1534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":5774,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1534},"source":{"system":"sec-edgar","filing":"0001127602-21-006270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006270/form4.xml","form_type":"4"}},{"id":2856329,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2021-02-17T21:58:28.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":477,"price":278.03,"value":132620.31,"ownership":{"direct":true},"balance_after":6006,"source":{"system":"sec-edgar","filing":"0001127602-21-006270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006270/form4.xml","form_type":"4"}},{"id":2856328,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2021-02-17T21:58:28.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":463,"price":278.03,"value":128727.89,"ownership":{"direct":true},"balance_after":6483,"source":{"system":"sec-edgar","filing":"0001127602-21-006270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006270/form4.xml","form_type":"4"}},{"id":2856327,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2021-02-17T21:58:28.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":1622,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6946,"source":{"system":"sec-edgar","filing":"0001127602-21-006270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006270/form4.xml","form_type":"4"}},{"id":2856326,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2021-02-17T21:58:28.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":1534,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5324,"source":{"system":"sec-edgar","filing":"0001127602-21-006270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006270/form4.xml","form_type":"4"}},{"id":2959392,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2020-12-03T22:41:07.000Z","date":"2020-12-01","kind":"other","acquired":false,"shares":693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":693},"source":{"system":"sec-edgar","filing":"0001127602-20-030492","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220030492/form4.xml","form_type":"4"}},{"id":2959391,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2020-12-03T22:41:07.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":693,"derivative":{"exercise_price":0,"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":481},"source":{"system":"sec-edgar","filing":"0001127602-20-030492","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220030492/form4.xml","form_type":"4"}},{"id":2959390,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2020-12-03T22:41:07.000Z","date":"2020-12-01","kind":"tax_withholding","acquired":false,"shares":214,"price":243.16,"value":52036.24,"ownership":{"direct":true},"balance_after":3790,"source":{"system":"sec-edgar","filing":"0001127602-20-030492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220030492/form4.xml","form_type":"4"}},{"id":2959389,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2020-12-03T22:41:07.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":481,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4004,"source":{"system":"sec-edgar","filing":"0001127602-20-030492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220030492/form4.xml","form_type":"4"}},{"id":2959388,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2020-12-03T22:41:07.000Z","date":"2020-12-01","kind":"tax_withholding","acquired":false,"shares":348,"price":243.16,"value":84619.68,"ownership":{"direct":true},"balance_after":3523,"source":{"system":"sec-edgar","filing":"0001127602-20-030492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220030492/form4.xml","form_type":"4"}},{"id":3272150,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:34:41.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":11450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":11450,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":11450},"source":{"system":"sec-edgar","filing":"0001127602-20-005780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005780/form4.xml","form_type":"4"}},{"id":3272149,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:34:41.000Z","date":"2020-02-12","kind":"other","acquired":false,"shares":1972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":7308,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1972},"source":{"system":"sec-edgar","filing":"0001127602-20-005780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005780/form4.xml","form_type":"4"}},{"id":3272148,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:34:41.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":1680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":9280,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1680},"source":{"system":"sec-edgar","filing":"0001127602-20-005780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005780/form4.xml","form_type":"4"}},{"id":3272147,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2020-02-14T23:34:41.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":504,"price":331.76,"value":167207.04,"ownership":{"direct":true},"balance_after":3871,"source":{"system":"sec-edgar","filing":"0001127602-20-005780","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005780/form4.xml","form_type":"4"}},{"id":3272146,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2020-02-14T23:34:41.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":1680,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4375,"source":{"system":"sec-edgar","filing":"0001127602-20-005780","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005780/form4.xml","form_type":"4"}},{"id":3355123,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2019-12-03T22:59:49.000Z","date":"2019-12-01","kind":"other","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":1174,"derivative":{"exercise_price":0,"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001127602-19-034176","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219034176/form4.xml","form_type":"4"}},{"id":3355122,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Restricted Stock Unit","published_at":"2019-12-03T22:59:49.000Z","date":"2019-12-01","kind":"exercise","acquired":false,"shares":543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":1799,"derivative":{"exercise_price":0,"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":543},"source":{"system":"sec-edgar","filing":"0001127602-19-034176","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219034176/form4.xml","form_type":"4"}},{"id":3355121,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2019-12-03T22:59:49.000Z","date":"2019-12-01","kind":"tax_withholding","acquired":false,"shares":160,"price":299.81,"value":47969.6,"ownership":{"direct":true},"balance_after":2695,"source":{"system":"sec-edgar","filing":"0001127602-19-034176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219034176/form4.xml","form_type":"4"}},{"id":3355120,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2019-12-03T22:59:49.000Z","date":"2019-12-01","kind":"exercise","acquired":true,"shares":543,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2855,"source":{"system":"sec-edgar","filing":"0001127602-19-034176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219034176/form4.xml","form_type":"4"}},{"id":3355119,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Prod Strat and Comm"}}],"security":"Common Stock","published_at":"2019-12-03T22:59:49.000Z","date":"2019-12-01","kind":"tax_withholding","acquired":false,"shares":231,"price":299.81,"value":69256.11,"ownership":{"direct":true},"balance_after":2312,"source":{"system":"sec-edgar","filing":"0001127602-19-034176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219034176/form4.xml","form_type":"4"}},{"id":3658370,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Mkt Acc & Cust Innov"}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T23:11:45.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":10960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":10960,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":10960},"source":{"system":"sec-edgar","filing":"0001127602-19-006082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219006082/form4.xml","form_type":"4"}},{"id":3744957,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Mkt Acc & Cust Innov"}}],"security":"Restricted Stock Unit","published_at":"2018-12-05T01:21:37.000Z","date":"2018-12-01","kind":"other","acquired":false,"shares":566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":2342,"derivative":{"exercise_price":0,"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":566},"source":{"system":"sec-edgar","filing":"0001127602-18-035245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218035245/form4.xml","form_type":"4"}},{"id":3744956,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Mkt Acc & Cust Innov"}}],"security":"Restricted Stock Unit","published_at":"2018-12-05T01:21:37.000Z","date":"2018-12-01","kind":"exercise","acquired":false,"shares":602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":2908,"derivative":{"exercise_price":0,"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":602},"source":{"system":"sec-edgar","filing":"0001127602-18-035245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218035245/form4.xml","form_type":"4"}},{"id":3744955,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Mkt Acc & Cust Innov"}}],"security":"Common Stock","published_at":"2018-12-05T01:21:37.000Z","date":"2018-12-01","kind":"tax_withholding","acquired":false,"shares":178,"price":333.72,"value":59402.16,"ownership":{"direct":true},"balance_after":2543,"source":{"system":"sec-edgar","filing":"0001127602-18-035245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218035245/form4.xml","form_type":"4"}},{"id":3744954,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Mkt Acc & Cust Innov"}}],"security":"Common Stock","published_at":"2018-12-05T01:21:37.000Z","date":"2018-12-01","kind":"exercise","acquired":true,"shares":602,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2721,"source":{"system":"sec-edgar","filing":"0001127602-18-035245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218035245/form4.xml","form_type":"4"}},{"id":3744953,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Mkt Acc & Cust Innov"}}],"security":"Common Stock","published_at":"2018-12-05T01:21:37.000Z","date":"2018-12-01","kind":"tax_withholding","acquired":false,"shares":231,"price":333.72,"value":77089.32,"ownership":{"direct":true},"balance_after":2119,"source":{"system":"sec-edgar","filing":"0001127602-18-035245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218035245/form4.xml","form_type":"4"}},{"id":4104641,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Mkt Acc & Cust Innov"}}],"security":"Restricted Stock Unit","published_at":"2018-01-08T21:31:33.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":3510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In the original Form 4, the number of Restricted Stock Units acquired was reported at the target payout and should have been reported at the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":3510,"derivative":{"exercise_price":0,"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":3510},"source":{"system":"sec-edgar","filing":"0001127602-18-001380","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218001380/form4a.xml","form_type":"4/A","original_submission_date":"2017-12-05"}},{"id":4143218,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Mkt Acc & Cust Innov"}}],"security":"Restricted Stock Unit","published_at":"2017-12-05T21:41:53.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":1755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":1755,"derivative":{"exercise_price":0,"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":1755},"source":{"system":"sec-edgar","filing":"0001127602-17-033939","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217033939/form4.xml","form_type":"4"}},{"id":4143217,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":10468,"kind":"person","name":"Guindo Chirfi","position":1,"cik":"0001722753","reported_name":"Guindo Chirfi","relationship":{"officer":true,"officer_title":"EVP Glob. Mkt Acc & Cust Innov"}}],"security":"Common Stock","published_at":"2017-12-05T21:41:53.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":2350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2350,"source":{"system":"sec-edgar","filing":"0001127602-17-033939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217033939/form4.xml","form_type":"4"}}]}